Related GWPH Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High GW Pharma Oncology Is Potential Underrated (Seeking Alpha)
Related ZYNE Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Benzinga's Top Upgrades, Downgrades For February 24, 2017 Zynerba Pharmaceuticals Undervalued Compared To GW Pharmaceuticals (Seeking Alpha)
Top cannabis stocks took a hit Friday, after White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized, even in spite of the Cole Memo.
Top 5 Undervalued Stocks To Buy For 2019: First Financial Corporation Indiana(THFF)
- [By Stephan Byrd]
First Financial Co. Indiana (NASDAQ:THFF) declared a semiannual dividend on Thursday, May 17th, Wall Street Journal reports. Investors of record on Friday, June 15th will be given a dividend of 0.51 per share by the bank on Monday, July 2nd. This represents a dividend yield of 2.33%. The ex-dividend date of this dividend is Thursday, June 14th.
Top 5 Undervalued Stocks To Buy For 2019: CNA Financial Corporation(CNA)
- [By Joseph Griffin]
JPMorgan Chase restated their neutral rating on shares of Centrica (LON:CNA) in a research report released on Tuesday.
Several other equities research analysts have also recently weighed in on CNA. Credit Suisse Group reiterated an outperform rating on shares of Centrica in a research report on Friday, May 4th. Kepler Capital Markets decreased their price objective on shares of Centrica from GBX 190 ($2.58) to GBX 160 ($2.17) and set a buy rating for the company in a research report on Wednesday, February 28th. Royal Bank of Canada raised shares of Centrica to an outperform rating and increased their target price for the stock from GBX 150 ($2.03) to GBX 175 ($2.37) in a research note on Monday, February 26th. HSBC lowered shares of Centrica to a reduce rating and cut their target price for the stock from GBX 150 ($2.03) to GBX 120 ($1.63) in a research note on Wednesday, April 11th. Finally, Deutsche Bank reissued a sell rating and set a GBX 125 ($1.70) target price on shares of Centrica in a research note on Wednesday, January 31st. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of GBX 174.63 ($2.37).
Top 5 Undervalued Stocks To Buy For 2019: Evoke Pharma, Inc.(EVOK)
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Evoke Pharma (EVOK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Undervalued Stocks To Buy For 2019: Valeant Pharmaceuticals International Inc(VRX)
- [By Lisa Levin] Gainers
ProPhase Labs, Inc. (NASDAQ: PRPH) gained 50.7 percent to $4.34 after the company announced a special $1.00 per share cash dividend.
Impinj, Inc. (NASDAQ: PI) surged 28.4 percent to $17.44 after reporting Q1 results.
Cardlytics, Inc. (NASDAQ: CDLX) gained 22 percent to $17.945.
Care.com, Inc. (NYSE: CRCM) shares rose 19.3 percent to $18.92 following Q1 earnings.
Sharing Economy International Inc. (NASDAQ: SEII) jumped 19.1 percent to $4.3934 after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
Blink Charging Co. (NASDAQ: BLNK) rose 18.6 percent to $4.79 after jumping 171.14 percent on Monday.
IntriCon Corporation (NASDAQ: IIN) climbed 17.4 percent to $29.30 after reporting Q1 results.
Nevsun Resources Ltd. (NYSE: NSU) rose 16.2 percent to $3.45 after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
Tactile Systems Technology, Inc. (NASDAQ: TCMD) gained 15.4 percent to $42.61 following Q1 results.
eGain Corporation (NASDAQ: EGAN) gained 15.3 percent to $10.55 following Q3 earnings.
Dean Foods Company (NYSE: DF) rose 13.8 percent to $9.48 after reporting upbeat Q1 earnings.
Sterling Construction Company, Inc. (NASDAQ: STRL) shares surged 13.1 percent to $13.42 after reporting Q1 results.
USA Technologies, Inc. (NASDAQ: USAT) climbed 11.9 percent to $10.85 following better-than-expected Q3 earnings.
scPharmaceuticals Inc. (NASDAQ: SCPH) gained 11.2 percent to $14.45 following Q1 results.
Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 10.2 percent to $24.08 following Q1 results.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 7.9 percent to $19.60 as the company posted upbeat Q1 results and raised its outlook.
Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 7.7 percent to $11.90 following upbeat Q1 results.
Pareteum Corporation (NASDAQ: TEUM) rose 6.8 perc
- [By Craig Jones]
Steve Sosnick of Interactive Brokers suggested on Bloomberg Markets an options strategy in Valeant Pharmaceuticals Intl Inc (NYSE: VRX).
The company is going to report earnings next week and Sosnick wants to use elevated implied volatility to sell options. He wants to sell the May 11, 17.50 strike call and buy the May 11, 19 strike call for a total credit of 60 cents.
- [By Lisa Levin] Gainers
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
- [By Chris Lange]
Look for the Valeant Pharmaceuticals International Inc. (NYSE: VRX) fourth-quarter report on Wednesday as well. The consensus forecast is $0.98 in EPS on $2.17 billion in revenue. Shares last traded at $18.68. The consensus price target is $17.29, and shares have traded between $8.31 and $24.43 in the past 52 weeks.
Top 5 Undervalued Stocks To Buy For 2019: Tata Motors Ltd(TTM)
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday
- [By Nicholas Rossolillo]
Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) autonomous car division, Waymo, recently signed a contract to add Jaguar’s first all-electric car to its fleet of self-driving vehicles. For the Google parent company, the deal will be a blip on its pathto driving automation, albeit an exciting one. For shareholders of Jaguar parent Tata Motors (NYSE:TTM), it’s an early sign the new vehicle will be a winner for the automaker.
- [By Joseph Griffin]
Tata Motors (NYSE:TTM) shares reached a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $22.73 and last traded at $22.79, with a volume of 102407 shares trading hands. The stock had previously closed at $22.92.
- [By Paul Ausick]
Tata Motors Ltd. (NYSE: TTM) fell by about 2% Monday to post a new 52-week low of $23.82 after closing at $24.30 on Friday. The 52-week high is $37.62. Volume of about 3.6 million was more more than double the daily average of about 1.5 million. The company had no specific news.